MedTrace Logo

Neoadjuvant Radiation in Locally Advanced Breast Cancer

NCT05479409 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-07-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether neoadjuvant radiation therapy is effective in improving local-regional control and to explore predictors of response to treatment in inoperable breast cancer patients after 2-6 courses of neoadjuvant chemotherapy.

Conditions

  • Breast Neoplasms

Interventions

RADIATION

Neoadjuvant radiotherapy

radiation therapy combined with chemotherapy prior to surgery

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Xiaoli Yu · Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05479409 on ClinicalTrials.gov